Clinical Trial Update: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (NCT06853665) is evaluating the treatment efficacy of mixed amphetamine for ADHD and autism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Mixed Amphetamine (mixed amphetamine salts)

Snippet

Sponsor: Gagan Joshi | Conditions: Attention Deficit Hyperactivity Disorder (ADHD), Autism | Phase 4 | Status: RECRUITING